SCMP Financial Facts

Net income (loss): 1.48M
Research and development revenue: 1.8M
See Full Income Statement

Other liabilities: 1.51M
Accumulated deficit: -23.01M
See Full Balance Sheet

Sucampo Pharmaceuticals (SCMP) Earnings

  |   Expand Research on SCMP
Next EPS Date 3/13/15 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate +31.3% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +12.1% Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/6/14 Q313 $0.03$0.04 -$0.01$31.5M$26.11M N/A Details
8/5/14 Q213 $0.04$0.03 +$0.01$24.1M$24.06M N/A Details
5/7/14 Q113 $0.02$0.04 -$0.02$22.2M$24.19M N/A Details
3/13/13 Q412 $0.32$0.12 +$0.20$34.9M$32.21M N/A Details
3/13/12 Q411 $0.06N/A N/A $14.22M$15.9M N/A Details
11/3/11 Q311 -$0.10N/A N/A $14.37M$20.9M N/A Details
3/3/11 Q410 -$0.15-$0.01 -$0.14$12.4M$15.5M N/A Details